Article

Coaxial 2.2-mm microphacoemulsification reduces surgically induced astigmatism

Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision results in significantly less induced astigmatism than conventional coaxial phacoemulsification through a 3-mm incision, said Samuel Masket, MD, clinical professor of ophthalmology, Jules Stein Eye Institute, University of California-Los Angeles, United States.

Lisbon, Portugal - Coaxial microphacoemulsification performed through a 2.2-mm incision results in significantly less induced astigmatism than conventional coaxial phacoemulsification through a 3-mm incision, said Samuel Masket, MD, clinical professor of ophthalmology, Jules Stein Eye Institute, University of California-Los Angeles, United States.

To study whether the new small incision coaxial technique has an advantage for being more astigmatically neutral, Dr. Masket performed a comparative clinical study. Patients included had no surgical complications or corneal pathology, and all surgeries were performed through a temporally oriented clear corneal tunnel incision. The coaxial microphacoemulsification technique was done using a 1.1 mm tip and the new ultra-infusion sleeve using the Infiniti system (Alcon Laboratories). No eyes had limbal relaxing incisions and astigmatism was measured preoperatively and after 6 weeks with autokeratometry by a masked technician.

Data from a series of 32 eyes showed surgically induced astigmatism was 0.11 D for the 2.2-mm incision group compared with 0.33 D for the 3-mm incision group (p = 0.001). The axis shift was also significantly less with the smaller incision compared with the 3-mm incision, 13.4 versus 21.1° (p = 0.03). Results were similar in a second group of 16 patients who had surgery through a 2.2-mm incision in one eye and a 3-mm incision contralaterally.

“These data show a statistically significant and possibly clinically significant advantage for the smaller incision. Further studies should be directed toward investigating whether the smaller incision also has benefits for better wound stability, leakage, and risk of postoperative infection,” Dr. Masket said. He has no financial interest in Alcon Laboratories.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.